Bravecto for Dogs: Complete Dosage, Safety, and Side Effect Guide
Everything about Bravecto for dogs: how this 12-week flea and tick chew works, dosage by weight, side effects, drug interactions, and cost breakdown.
If your dog scratches constantly, shakes their head, or you've spotted ticks embedded in their coat, your veterinarian may recommend Bravecto. This chewable tablet — or its topical counterpart — has become one of the most widely prescribed parasiticides in veterinary medicine since FDA approval in 2014. Unlike monthly preventives, Bravecto provides up to 12 weeks of continuous flea and tick protection from a single dose, which means fewer missed doses and fewer pharmacy trips.
But longer-lasting protection also means the active ingredient, fluralaner, stays in your dog's system for roughly three months. That extended duration raises legitimate questions about side effects, drug interactions, and whether it's the right choice for your specific dog. This guide breaks down the pharmacology, real-world dosing, safety data, and costs so you can have an informed conversation with your veterinarian.
What Is Bravecto and What Is It Used For in Dogs?
Bravecto is the brand name for fluralaner, a systemic parasiticide manufactured by Merck Animal Health (known as MSD Animal Health outside the United States). It belongs to the isoxazoline drug class, which includes other common flea-and-tick preventives like NexGard (afoxolaner), Simparica (sarolaner), and Credelio (lotilaner).
FDA-Approved Uses
The U.S. Food and Drug Administration approved Bravecto for the following indications in dogs:
- Flea treatment and prevention: Kills adult fleas (Ctenocephalides felis) and prevents flea infestations for up to 12 weeks
- Tick treatment and control: Effective against black-legged tick (deer tick), American dog tick, brown dog tick, and lone star tick for up to 12 weeks (8 weeks for lone star ticks)
- Flea allergy dermatitis (FAD): As part of a treatment strategy for dogs with flea bite hypersensitivity
- Demodicosis treatment: Approved for treating generalized demodectic mange caused by Demodex canis
Common Off-Label Uses
Veterinarians may prescribe Bravecto off-label for sarcoptic mange (Sarcoptes scabiei) and certain other mite infestations. While the FDA label covers demodicosis specifically, published studies in Parasites & Vectors have demonstrated fluralaner's efficacy against sarcoptic mange, and many dermatologists use it as part of a mange treatment protocol. Your vet will determine whether off-label use is appropriate for your dog's specific condition.
How Does Bravecto Work? Mechanism of Action Explained
Drug Class: Isoxazoline (systemic ectoparasiticide)
Active Ingredient: Fluralaner
Target: Parasite nervous system — specifically ligand-gated chloride channels (GABA-gated and glutamate-gated)
When your dog chews and swallows a Bravecto tablet, fluralaner is absorbed through the gastrointestinal tract and distributed systemically through the bloodstream. The drug reaches peak plasma concentration within approximately 2 hours of administration.
Here's where the pharmacology gets interesting — and important for understanding both efficacy and safety:
- Parasite bites the dog: When a flea or tick feeds on your dog's blood, it ingests fluralaner circulating in the plasma.
- Chloride channel blockade: Fluralaner binds to GABA-gated and glutamate-gated chloride channels in the parasite's central nervous system. These channels regulate nerve signal transmission.
- Hyperexcitation and death: By blocking chloride ion flow, fluralaner causes uncontrolled neural excitation in the parasite, leading to paralysis and death. Fleas begin dying within 2 hours; most are killed within 12 hours of the first dose.
- Extended half-life: Fluralaner has an elimination half-life of approximately 15 days in dogs, which is what enables the 12-week duration. The drug is primarily excreted through feces (via biliary excretion) with minimal renal clearance.
Why this matters for safety: Mammalian GABA receptors have a different structural configuration than invertebrate receptors, which is why fluralaner selectively targets parasites at therapeutic doses. However, at high enough concentrations, isoxazolines can affect mammalian neural tissue — which is why the FDA issued a safety alert in September 2018 regarding potential neurologic adverse events in the isoxazoline class. More on this below.
Bravecto Dosage Guide by Dog Weight and Condition
Bravecto chewable tablets are formulated in specific weight-based strengths. Your veterinarian will select the correct tablet based on your dog's current body weight — not their target weight or breed standard weight.
| Weight Range | Tablet Strength (mg fluralaner) | Dose (mg/kg) | Tablet Color/Marking |
|---|---|---|---|
| 4.4 – 9.9 lb (2 – 4.5 kg) | 112.5 mg | 25 – 56 mg/kg | Yellow |
| 9.9 – 22 lb (4.5 – 10 kg) | 250 mg | 25 – 56 mg/kg | Orange |
| 22 – 44 lb (10 – 20 kg) | 500 mg | 25 – 56 mg/kg | Green |
| 44 – 88 lb (20 – 40 kg) | 1000 mg | 25 – 56 mg/kg | Blue |
| 88 – 123 lb (40 – 56 kg) | 1400 mg | 25 – 56 mg/kg | Purple |
Minimum effective dose: The labeled dose provides a minimum of 25 mg/kg fluralaner. Dogs weighing more than 123 lb will require a combination of tablets to achieve the correct dose.
Administration Instructions
- Give with food: Bravecto chewable tablets must be administered with or shortly after a meal. Food significantly increases fluralaner absorption — studies show bioavailability increases by approximately 2.5-fold when given with food versus on an empty stomach.
- Frequency: Every 12 weeks (84 days) for flea and tick prevention. For demodicosis treatment, your veterinarian may recommend dosing every 4 weeks for 2–3 treatments depending on severity.
- Duration of therapy: For routine flea and tick prevention, Bravecto can be used year-round indefinitely. For mange treatment, duration is determined by skin scraping results — typically 2 to 3 doses at 4-week intervals.
- Tablet is palatable: Most dogs accept the chewable willingly. If your dog refuses, the tablet can be hidden in a small amount of food, but it must be fully consumed for the dose to be effective.
What Are the Side Effects of Bravecto in Dogs?
In pre-approval clinical trials and post-market surveillance, Bravecto demonstrated a generally favorable safety profile. However, as with any systemic medication, adverse events do occur. Understanding the frequency and severity helps you monitor appropriately.
Common Side Effects
| Side Effect | Reported Frequency | Typical Duration | Severity |
|---|---|---|---|
| Vomiting | 1.6% – 2.2% | Usually within 24 hours of dosing | Mild, self-limiting |
| Decreased appetite | 1.0% – 1.4% | 1–2 days | Mild |
| Diarrhea | 0.8% – 1.5% | 1–3 days | Mild, self-limiting |
| Lethargy / decreased activity | 0.5% – 0.8% | 12–48 hours | Mild to moderate |
| Increased thirst (polydipsia) | 0.4% – 0.6% | 1–2 days | Mild |
| Flatulence | < 0.5% | 1–3 days | Mild |
Serious Side Effects — When to Call Your Vet Immediately
🚨 Seek immediate veterinary attention if your dog exhibits any of the following after receiving Bravecto:
- Seizures or convulsions — The FDA's 2018 isoxazoline safety alert specifically noted muscle tremors, ataxia (loss of coordination), and seizures as potential neurologic adverse events. These can occur even in dogs without a prior seizure history.
- Muscle tremors or uncontrolled shaking — Especially if persistent beyond 30 minutes or worsening
- Ataxia (stumbling, inability to walk normally) — Particularly in the hind limbs
- Severe or persistent vomiting — More than 3 episodes in 24 hours, or vomiting with blood
- Facial swelling, hives, or difficulty breathing — Signs of anaphylaxis (rare but possible)
According to the Merck Veterinary Manual, the incidence of neurologic adverse events with isoxazolines is low but not negligible. Dogs with a pre-existing seizure disorder or those on medications that lower the seizure threshold are at higher risk. The FDA recommends that veterinarians use caution when prescribing isoxazolines to dogs with a history of neurologic disorders.
Post-Market Surveillance Data
The FDA's Center for Veterinary Medicine tracks adverse event reports through the Safety Reporting Portal. As of recent data, fluralaner products have generated thousands of adverse event reports — but this must be contextualized against the millions of doses administered. The reported adverse event rate for Bravecto is estimated at approximately 1–2 events per 10,000 doses, which is comparable to other oral parasiticides. However, the proportion of neurologic events within those reports has drawn regulatory attention.
Contraindications: Which Dogs Should NOT Receive Bravecto?
Bravecto is not appropriate for every dog. The following contraindications are based on the FDA label, published pharmacology data, and clinical veterinary consensus:
- Puppies under 6 months of age: Bravecto is not approved for dogs younger than 6 months. Young puppies have immature hepatic metabolism and blood-brain barrier function, which may increase neurologic risk.
- Dogs weighing less than 4.4 lb (2 kg): The lowest available tablet strength would deliver an excessive dose to a dog below this weight threshold.
- Dogs with known hypersensitivity to fluralaner: Any prior allergic reaction to Bravecto or other isoxazolines is an absolute contraindication.
- Dogs with a history of seizure disorders: While not an absolute contraindication on the label, the FDA and many veterinary neurologists recommend avoiding isoxazolines in dogs with idiopathic epilepsy or other seizure conditions. Discuss alternative parasiticide classes with your veterinarian.
- Dogs with severe hepatic impairment: Since fluralaner is primarily metabolized by the liver and excreted via bile, dogs with significant liver disease may have prolonged drug exposure. Your vet may adjust dosing or select an alternative.
Drug Interactions and Concurrent Medications
| Concurrent Drug / Substance | Interaction Type | Clinical Significance | Action Required |
|---|---|---|---|
| Phenobarbital, potassium bromide, levetiracetam (anti-seizure medications) | Pharmacodynamic — both drug classes can affect neural excitability | Theoretical increased seizure risk; clinical data limited | Avoid isoxazolines; use topical alternative |
| NSAIDs (carprofen, meloxicam, deracoxib) | No direct pharmacokinetic interaction identified | Low risk; widely co-prescribed in clinical practice | Generally safe; monitor for GI signs |
| Ivermectin / milbemycin (heartworm preventives) | No clinically significant interaction reported | Commonly used together; no dose adjustment needed | Safe to combine |
| Corticosteroids (prednisone, dexamethasone) | No direct interaction; both may cause GI effects | Additive GI upset possible | Monitor for vomiting/diarrhea |
| Other isoxazolines (NexGard, Simparica, Credelio) | Duplicate therapy — same drug class | Risk of overdose; additive neurologic toxicity | NEVER combine — choose one product |
| Hepatic enzyme inducers (phenobarbital) | Pharmacokinetic — may accelerate fluralaner metabolism | Potentially reduced efficacy duration | May need shorter dosing interval; consult vet |
Critical warning: Never give your dog two isoxazoline products simultaneously. If you're switching from NexGard, Simparica, or Credelio to Bravecto, wait until the full dosing interval of the previous product has elapsed before administering Bravecto. Your veterinarian will calculate the safe transition window.
How Long Does My Dog Need to Be on Bravecto?
The duration depends entirely on what you're treating:
For Flea and Tick Prevention (Most Common Use)
Year-round, lifelong administration is recommended in most of the United States. Fleas can survive indoors during winter months, and ticks in many regions remain active whenever temperatures exceed 40°F (4°C). The Companion Animal Parasite Council (CAPC) recommends continuous, year-round parasite prevention for all dogs regardless of climate or lifestyle.
At the 12-week dosing interval, that's approximately 4 to 5 doses per year — compared to 12 doses for monthly products. This reduced frequency is Bravecto's primary convenience advantage and reduces the risk of missed doses.
For Demodicosis (Demodectic Mange) Treatment
Typical treatment duration is 2 to 3 doses at 4-week intervals (not the standard 12-week interval). Your veterinarian will perform follow-up skin scrapings to confirm mite elimination before discontinuing treatment. Most dogs show clinical improvement within 4–8 weeks, but complete resolution may take 8–12 weeks.
For Sarcoptic Mange (Off-Label)
Published protocols typically use 2 doses at 4-week intervals. Resolution is confirmed by negative skin scrapings and clinical improvement.
Monitoring Requirements and Follow-Up
Routine Prevention — Minimal Monitoring
For healthy dogs on Bravecto for standard flea and tick prevention, no routine blood work or lab monitoring is required. Your veterinarian will:
- Confirm your dog's current weight at each visit to ensure correct dosing
- Ask about any adverse events since the last dose
- Assess for flea/tick breakthrough (which may indicate environmental re-infestation rather than drug failure)
Mange Treatment — Active Monitoring
When treating demodicosis or sarcoptic mange, expect:
- Skin scrapings every 4 weeks until two consecutive negative results
- Physical examination to assess hair regrowth, skin inflammation, and secondary infections
- Possible antibiotic therapy if secondary bacterial pyoderma is present
Dogs with Pre-Existing Conditions — Enhanced Monitoring
If your dog has hepatic disease, is on concurrent medications, or has a history of neurologic events:
- Serum biochemistry panel (liver enzymes: ALT, ALP, bilirubin) at baseline and periodically
- Neurologic monitoring — owners should watch for tremors, ataxia, behavioral changes
- More frequent recheck appointments — typically every 4–8 weeks during initial treatment
Cost Breakdown: Bravecto Pricing and Availability
Bravecto pricing varies by dog weight, retailer, and whether you purchase through your veterinary clinic or an approved online pharmacy. Below are typical 2026 retail ranges:
| Weight Range | Single Dose (1 tablet) | 2-Pack (6 months) | Annual Cost (4–5 doses) |
|---|---|---|---|
| 4.4 – 9.9 lb | $44 – $52 | $82 – $98 | $176 – $260 |
| 9.9 – 22 lb | $48 – $56 | $90 – $108 | $192 – $280 |
| 22 – 44 lb | $50 – $58 | $96 – $112 | $200 – $290 |
| 44 – 88 lb | $54 – $64 | $104 – $124 | $216 – $320 |
| 88 – 123 lb | $58 – $68 | $112 – $132 | $232 – $340 |
Generic Availability
As of 2026, no generic fluralaner product is available in the United States. Bravecto remains under patent protection by Merck Animal Health. This means you won't find a cheaper generic equivalent — any product claiming to be "generic Bravecto" from an unauthorized source should be considered suspect and potentially counterfeit.
Where to Purchase Safely
Bravecto should only be purchased from:
- Your veterinary clinic (most reliable source, often with rebates)
- Vet-operated online pharmacies (VetSource, Covetrus/Vetsource)
- Accredited online pharmacies verified through the National Association of Boards of Pharmacy (NABP)
- Chewy.com, 1800PetMeds, or PetCareRx (requires valid vet prescription verification)
Warning: Products purchased from Amazon third-party sellers, eBay, or overseas pharmacies without prescription verification may be counterfeit, expired, or improperly stored — all of which compromise efficacy and safety.
Missed Dose and Overdose: What to Do
If You Miss a Dose
Because Bravecto is dosed every 12 weeks, missing a dose means your dog may have an unprotected gap. Here's the protocol:
- Administer the missed dose as soon as you remember. There's no need to wait for the original schedule date.
- Reset the 12-week clock from the date of the late dose — not the originally scheduled date.
- Check for parasite exposure: If you live in a high-tick area (Northeast, Upper Midwest) and the gap exceeded 14 weeks, examine your dog thoroughly for attached ticks and watch for signs of tick-borne illness (lethargy, fever, joint swelling, loss of appetite) over the next 2–4 weeks.
- Consult your veterinarian if the gap was longer than 4 weeks beyond the scheduled date — they may recommend a tick-borne disease screening panel.
If an Overdose Occurs
In safety studies, dogs received doses up to 5 times the maximum labeled dose (approximately 280 mg/kg) without life-threatening effects. However, overdose increases the likelihood and severity of adverse events, particularly gastrointestinal and neurologic signs.
If your dog accidentally receives more than the prescribed dose:
- Note the exact amount consumed and the time of ingestion.
- Contact your veterinarian or an emergency veterinary clinic immediately.
- Call the ASPCA Animal Poison Control Center at (888) 426-4435 (24/7, consultation fee applies) or the Pet Poison Helpline at (855) 764-7661.
- Monitor for vomiting, tremors, ataxia, or seizures over the next 24–48 hours.
- Do NOT attempt to induce vomiting unless specifically instructed by a veterinarian or poison control specialist.
Are There Alternatives to Bravecto?
Bravecto isn't the only option. Your veterinarian may recommend an alternative based on your dog's health history, your compliance preferences, or specific parasite risks in your area. Here's how the major options compare:
| Product | Active Ingredient | Dosing Interval | Form | Minimum Age | Heartworm Coverage |
|---|---|---|---|---|---|
| Bravecto | Fluralaner | 12 weeks | Chewable / Topical | 6 months | No |
| Bravecto Plus (topical) | Fluralaner + Moxidectin | 12 weeks | Topical | 6 months | Yes |
| NexGard | Afoxolaner | Monthly | Chewable | 8 weeks | No |
| Simparica Trio | Sarolaner + Moxidectin + Pyrantel | Monthly | Chewable | 8 weeks | Yes |
| Credelio | Lotilaner | Monthly | Chewable | 8 weeks | No |
| Seresto Collar | Imidacloprid + Flumethrin | 8 months | Collar | 7 weeks | No |
| Frontline Plus | Fipronil + (S)-methoprene | Monthly | Topical | 8 weeks | No |
Key consideration: None of the standalone Bravecto products cover heartworm. If you want flea, tick, and heartworm prevention in fewer products, your vet may recommend Bravecto combined with a separate heartworm preventive (like Heartgard Plus or Interceptor Plus), or switching to a combination product like Simparica Trio or Bravecto Plus (topical formulation with moxidectin).
Frequently Asked Questions About Bravecto for Dogs
Can I give Bravecto to my pregnant or nursing dog?
Bravecto has been evaluated for safety in breeding, pregnant, and lactating dogs. The FDA-approved label states that Bravecto is safe for use in these populations. However, as with any medication during pregnancy, your veterinarian should weigh the benefits against potential risks for your individual dog.
Does Bravecto protect against heartworm?
No. Standard Bravecto (chewable tablets and the standalone topical) does not cover heartworm (Dirofilaria immitis). You'll need a separate heartworm preventive. Bravecto Plus (topical only) includes moxidectin for heartworm prevention, but the chewable formulation does not. Consult your veterinarian about a complete prevention strategy.
My dog threw up within an hour of taking Bravecto. Should I redose?
If vomiting occurs within 2 hours of administration, a significant portion of the dose may not have been absorbed. Contact your veterinarian — they will likely recommend redosing. If vomiting occurs more than 4 hours after dosing, the drug has typically been absorbed sufficiently and redosing is not necessary. Always consult your vet rather than making this judgment on your own.
Can Bravecto be used in dogs with MDR1 gene mutations?
The MDR1 (ABCB1) gene mutation, common in herding breeds like Australian Shepherds, Collies, and German Shepherds, affects drug transport across the blood-brain barrier. Fluralaner is not a known substrate of P-glycoprotein (the protein affected by the MDR1 mutation), so Bravecto is generally considered safe for MDR1-affected dogs. However, always inform your veterinarian of your dog's MDR1 status so they can make a complete risk assessment. Washington State University's Veterinary Genetics Laboratory offers affordable MDR1 testing if your dog's status is unknown.
Is there a Bravecto shortage in 2026?
Supply chain disruptions have periodically affected Bravecto availability. If your veterinary clinic or pharmacy is out of stock, ask about approved alternatives. Your vet can prescribe a different isoxazoline or a non-isoxazoline product to bridge the gap — just ensure there's an appropriate washout period between products.
Can I split a larger Bravecto tablet for a smaller dog to save money?
No. Bravecto tablets are not scored and are not designed to be split. The active ingredient may not be evenly distributed throughout the tablet, meaning a half-tablet could deliver either a sub-therapeutic dose (ineffective) or an excessive dose (increased side effect risk). Always use the tablet strength that matches your dog's weight range. Attempting to split tablets is both unsafe and violates the manufacturer's labeled instructions.
How quickly does Bravecto start killing fleas and ticks?
Bravecto begins killing fleas within 2 hours of administration and achieves greater than 98% flea kill within 12 hours. For ticks, kill rates exceed 95% within 48 hours. This rapid onset is one advantage over some topical products that require 24–48 hours to distribute across the skin surface.
This article is for informational purposes only and does not replace professional veterinary advice. Always consult your veterinarian before starting, stopping, or changing any medication for your dog. Individual responses to Bravecto may vary based on breed, health status, concurrent medications, and environmental factors.
Jonas Cole
All our authors care for dogs every day — read more of their work on the authors page.



